33
Registered trials
17
Recruiting
11
Completed trials
28
Sponsors
20
Countries
Phase III:
13
Phase II/III:
2
Phase II:
11
Phase I/II:
4
Phase IV:
1
Phase I (Other):
2
Oversight events:
1 serious breach
1 urgent safety measure
2 corrective measures
across 4 trials
View oversight register →
Indications tested
Triple negative breast cancer
2
Leiomyosarcoma metastatic
1
Neuroblastoma
1
Ovarian epithelial cancer
1
Soft tissue sarcoma
1
Acute on chronic liver failure
1
Fallopian tube cancer stage IV
1
HER2 positive breast cancer
1
Mantle cell lymphoma stage IV
1
Ovarian cancer stage IV
1
Sickle cell anaemia
1
Fallopian tube cancer stage III
1
Sponsors using this IMP
Fondazione Gimema Franco Mandelli Onlus
3
Vertex Pharmaceuticals Inc.
3
GPOH gGmbH
2
Merck Sharp & Dohme LLC
2
Alpha Bioresearch S.L.
1
Arcagy Gineco
1
Assistance Publique Hopitaux De Paris
1
Astellas Pharma Global Development Inc.
1
Azienda Provinciale Per I Servizi Sanitari
1
Champalimaud Clinical Centre
1
Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S
1
Genenta Science S.p.A.
1
All trials — page 2
33 totalShowing 25–33 of 33 trials